Role of Surgery for Locally Advanced and Metastatic Renal Cell Carcinoma

Restricted access

Both locally advanced and metastatic renal cell carcinoma (RCC) present a challenge in terms of their optimal management. This article reviews the literature and evaluates the role of surgery in the treatment of advanced RCC. Surgery is the optimal treatment for locally advanced RCC and minimal, resectable, metastatic disease. Patients with metastatic disease, and some forms of locally advanced disease, may also benefit from multimodal management with local surgical therapy and systemic treatment using either immunotherapy or targeted therapy. Regardless of the disease stage, patients with locally advanced or metastatic RCC represent heterogenous patient populations with different disease characteristics and risk factors. Individualization of care in the setting of a sound oncologic framework may optimize the risk/benefit ratio within individual patient cohorts.

Correspondence: David Josephson, MD, Tower Urology at Cedars-Sinai Office Towers, 8635 W. 3rd Street, Suite 1 West, Los Angeles, CA 90048. E-mail: josephsond@towerurology.com
  • 1

    EdgeSBByrdDRComptonCC. AJCC Cancer Staging Manual. New York, NY: Springer; 2010.

  • 2

    SchreyerHHUggowitzerMMRuppert-KohlmayrA. Helical CT of the urinary organs. Eur Radiol2002;12:575591.

  • 3

    Mueller-LisseUGMueller-LisseUL. Imaging of advanced renal cell carcinoma. World J Urol2010;28:253261.

  • 4

    FurnissDHarndenPAliN. Prognostic factors for renal cell carcinoma. Cancer Treat Rev2008;34:407426.

  • 5

    LaneBRKattanMW. Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am2008;35:613625.

  • 6

    HanKRBuiMHPantuckAJ. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol2003;169:899903.

    • Search Google Scholar
    • Export Citation
  • 7

    ThompsonRHLeibovichBCChevilleJC. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?J Urol2005;173:918921.

    • Search Google Scholar
    • Export Citation
  • 8

    FicarraVGalfanoAGuilleF. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol2007;178:418424.

    • Search Google Scholar
    • Export Citation
  • 9

    O’MalleyRLGodoyGKanofskyJA. The necessity of adrenalectomy at the time of radical nephrectomy: a systematic review. J Urol2009;18:20092017.

    • Search Google Scholar
    • Export Citation
  • 10

    SiemerSLehmannJKamradtJ. Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol2004;171:21552159.

    • Search Google Scholar
    • Export Citation
  • 11

    YokoyamaHTanakaM. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?BJU Int2005;95:526529.

    • Search Google Scholar
    • Export Citation
  • 12

    RobsonCJChurchillBMAndersonW. The results of radical nephrectomy for renal cell carcinoma. J Urol1969;101:297301.

  • 13

    KlatteTChungJLeppertJT. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma. BJU Int2007;99:821824.

    • Search Google Scholar
    • Export Citation
  • 14

    JeongIGJeongCWHongSK. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma. Urology2006;67:709712.

    • Search Google Scholar
    • Export Citation
  • 15

    YooCSongCHongJH. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. J Urol2008;180:486491.

    • Search Google Scholar
    • Export Citation
  • 16

    ThompsonRHLeibovichBCChevilleJC. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?J Urol2005;174:12181221.

    • Search Google Scholar
    • Export Citation
  • 17

    ThompsonRHBluteMLKrambeckAE. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol2007;31:10891093.

    • Search Google Scholar
    • Export Citation
  • 18

    PhillipsCKTanejaSS. The role of lymphadenectomy in the surgical management of renal cell carcinoma. Urol Oncol2004;22:214223.

  • 19

    BlomJHvan PoppelHMarechalJM. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol2009;55:2834.

    • Search Google Scholar
    • Export Citation
  • 20

    StuderUEBirkhauserFD. Lymphadenectomy combined with radical nephrectomy: to do or not to do?Eur Urol2009;55:3537.

  • 21

    TerroneCGuercioSDe LucaS. The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int2003;91:3740.

  • 22

    PhillipsEMessingEM. Role of lymphadenectomy in the treatment of renal cell carcinoma. Urology1993;41:915.

  • 23

    StuderUEScherzSScheideggerJ. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol1990;144:243245.

    • Search Google Scholar
    • Export Citation
  • 24

    MinerviniALilasLMorelliG. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?BJU Int2001;88:169172.

    • Search Google Scholar
    • Export Citation
  • 25

    PantuckAJZismanADoreyF. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol2003;169:20762083.

    • Search Google Scholar
    • Export Citation
  • 26

    KarakiewiczPITrinhQDBhojaniN. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol2007;51:16161624.

    • Search Google Scholar
    • Export Citation
  • 27

    CanfieldSEKamatAMSanchez-OrtizRF. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol2006;175:864869.

    • Search Google Scholar
    • Export Citation
  • 28

    BluteMLLeibovichBCLohseCM. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int2004;94:3341.

    • Search Google Scholar
    • Export Citation
  • 29

    WagnerBPatardJJMejeanA. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol2009;55:452459.

    • Search Google Scholar
    • Export Citation
  • 30

    MoinzadehALibertinoJA. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?J Urol2004;171:598601.

    • Search Google Scholar
    • Export Citation
  • 31

    KimHLZismanAHanKR. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?J Urol2004;171:588591.

    • Search Google Scholar
    • Export Citation
  • 32

    NevesRJZinckeH. Surgical treatment of renal cancer with vena cava extension. Br J Urol1987;59:390395.

  • 33

    VaidyaACiancioGSolowayM. Surgical techniques for treating a renal neoplasm invading the inferior vena cava. J Urol2003;169:435444.

  • 34

    SkinnerDGPritchettTRLieskovskyG. Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg1989;210:387392.

    • Search Google Scholar
    • Export Citation
  • 35

    CiancioGGonzolezJShirodkarSP. Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. Eur Urol2011;59:401406.

    • Search Google Scholar
    • Export Citation
  • 36

    PouliotFShuchBLarochelleJC. Contemporary management of renal tumors with venous tumor thrombus. J Urol;184:833841.

  • 37

    LawrentschukNGaniJRiordanR. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int2005;96:291295.

    • Search Google Scholar
    • Export Citation
  • 38

    HallscheidtPJFinkCHaferkampA. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr2005;29:6468.

    • Search Google Scholar
    • Export Citation
  • 39

    SigmanDBHasnainJUDel PizzoJJ. Real-time transesophageal echocardiography for intraoperative surveillance of patients with renal cell carcinoma and vena caval extension undergoing radical nephrectomy. J Urol1999;161:3638.

    • Search Google Scholar
    • Export Citation
  • 40

    ZismanAWiederJAPantuckAJ. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol2003;169:909916.

    • Search Google Scholar
    • Export Citation
  • 41

    CiancioGSolowayM. Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus. BJU Int2005;96:815818.

    • Search Google Scholar
    • Export Citation
  • 42

    DutyBDaneshmandS. Resection of the inferior vena cava without reconstruction for urologic malignancies. Urology2009;74:12571262.

  • 43

    MargulisVSanchez-OrtizRFTamboliP. Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer2007;109:20252030.

    • Search Google Scholar
    • Export Citation
  • 44

    CapitanioUPerrottePZiniL. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma). BJU Int2009;104:795799.

    • Search Google Scholar
    • Export Citation
  • 45

    KarakiewiczPISuardiNJeldresC. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol2008;53:845848.

    • Search Google Scholar
    • Export Citation
  • 46

    Di SilverioFSciarraAParenteU. Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol Int2008;80:451453.

    • Search Google Scholar
    • Export Citation
  • 47

    PatardJJThuretRRaffiA. Treatment with sunitinib enabled complete resection of massive lymphadenopathy not previously amenable to excision in a patient with renal cell carcinoma. Eur Urol2009;55:237239.

    • Search Google Scholar
    • Export Citation
  • 48

    ThomasAARiniBIStephensonAJ. Surgical resection of renal cell carcinoma after targeted therapy. J Urol2009;182:881886.

  • 49

    ThomasAARiniBILaneBR. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol2009;181:518523.

    • Search Google Scholar
    • Export Citation
  • 50

    Paez-RibesMAllenEHudockJ. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell2009;15:220231.

    • Search Google Scholar
    • Export Citation
  • 51

    EbosJMLeeCRCruz-MunozW. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell2009;15:232239.

    • Search Google Scholar
    • Export Citation
  • 52

    BexAJonaschEKirkaliZ. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur Urol2010; 58:819828.

    • Search Google Scholar
    • Export Citation
  • 53

    GuptaKMillerJDLiJZ. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev2008;34:193205.

    • Search Google Scholar
    • Export Citation
  • 54

    RiniBICampbellSC. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy. J Urol2007;177:19781984.

    • Search Google Scholar
    • Export Citation
  • 55

    FlaniganRCSalmonSEBlumensteinBA. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med2001;345:16551659.

    • Search Google Scholar
    • Export Citation
  • 56

    MickischGHGarinAvan PoppelH. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet2001;358:966970.

    • Search Google Scholar
    • Export Citation
  • 57

    FlaniganRCMickischGSylvesterR. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol2004;171:10711076.

    • Search Google Scholar
    • Export Citation
  • 58

    PantuckAJBelldegrunASFiglinRA. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma. N Engl J Med2001;345:17111712.

  • 59

    de ReijkeTMBellmuntJvan PoppelH. EORTC-GU group expert opinion on metastatic renal cell cancer. Eur J Cancer2009;45:765773.

  • 60

    McDermottDF. Update on the application of interleukin-2 in the treatment of renal cell carcinoma. Clin Cancer Res2007;13:716s720s.

  • 61

    SpiessPEFishmanMN. Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma. Cancer Control2010;17:269278.

    • Search Google Scholar
    • Export Citation
  • 62

    ThelenAJonasSBenckertC. Liver resection for metastases from renal cell carcinoma. World J Surg2007;31:802807.

  • 63

    ZerbiAOrtolanoEBalzanoG. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?Ann Surg Oncol2008;15:11611168.

    • Search Google Scholar
    • Export Citation
  • 64

    PiltzSMeimarakisGWichmannMW. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg2002;73:10821087.

    • Search Google Scholar
    • Export Citation
  • 65

    SherryRMPassHIRosenbergSA. Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy. Cancer1992;69:18501855.

    • Search Google Scholar
    • Export Citation
  • 66

    KavoliusJPMastorakosDPPavlovichC. Resection of metastatic renal cell carcinoma. J Clin Oncol1998;16:22612266.

  • 67

    KimBLouieAC. Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg1992;127:13431349.

    • Search Google Scholar
    • Export Citation
  • 68

    KaramJARiniBIVarellaL. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol2011;185:439444.

  • 69

    MargulisVMcDonaldMTamboliP. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol2009;181:20442051.

    • Search Google Scholar
    • Export Citation
  • 70

    LoganTMcDermottDDutcherJ. Exploratory analysis of the influence of nephrectomy status on temsirolimus efficacy in patients with advanced renal cell carcinoma and poor-risk features [abstract]. Presented at the 2009 Genitourinary Cancers Symposium; February 26–28, 2009; Orlando, Florida. Abstract 281.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 1 1 0
Full Text Views 62 62 5
PDF Downloads 8 8 0
EPUB Downloads 0 0 0